CASEY FORMAN: Open Payments
NPI 1750055307 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 60 payments from 15 companies in 2025. Trend: 2023 $1,742 · 2024 $1,323 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $420 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $145 |
| Ardelyx, Inc. | 7 | $121 |
| Lilly USA, LLC | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Celltrion USA Inc. | 3 | $65 |
| Madrigal Pharmaceuticals | 2 | $56 |
| PFIZER INC. | 2 | $49 |
| QOL Medical, LLC | 2 | $46 |
| Novo Nordisk Inc | 2 | $42 |
Products named: RINVOQ, IBSRELA, ENTYVIO, LINZESS, OMVOH, VEGZELMA, REZDIFFRA, XELJANZ.
Industry payments across VA — which companies pay providers there.
